Covid-19 tamaiti ma pepe: fa'ailoga, su'ega ma tui

Covid-19: what is the “immune debt”, from which children could suffer?

O loʻo lapataia e fomaʻi tamaiti e uiga i se taunuuga e leʻi taʻua e oʻo mai i le taimi nei o le faʻamaʻi COVID-19 i le soifua maloloina o tamaiti. O se mea e taʻua o le "aitalafu puipuia", pe a faʻaitiitia i mataupu o le tele o faʻamaʻi viral ma siama e mafua ai le le lava o le faʻamalosia.

Ole fa'ama'i ole COVID-19 ma fa'afitauli eseese hygiene and physical distancing measures implemented over several months will at least have made it possible to reduce the number of cases of well-known viral infectious diseases compared to previous years: influenza, chickenpox, measles… But is this really a good thing? Not necessarily, according to a study published by French pediatricians in the scientific journal “Science Direct”. The latter assert that the leai se fa'aosofia o le puipuiga due to the reduced circulation of microbial agents within the population and the numerous delays in vaccination programs have led to an “immune debt”, with an increasing proportion of susceptible people, aemaise lava tamaiti.

Ae ui i lea, o lenei tulaga "e mafai ona oʻo atu ai i faʻamaʻi tetele pe a tuʻuina atu faʻalavelave e le o ni vailaʻau e ala i le faʻamaʻi SARS-CoV-2 o le a le toe manaomia. “, Fefe i fomai. O lenei itu aʻafiaga na lelei i se taimi puʻupuʻu, aua na mafai ai ona aloese mai le tele o auaunaga a le falemaʻi i le lotolotoi o faʻafitauli tau soifua maloloina. Ae o le toesea fa'aosofia le puipuiga ona o le faʻaitiitia o le taʻavale o microbes ma siama, ma le pa'ū o le tui puipui, ua oʻo atu ai i se "aitalafu faʻamaʻi" e ono i ai ni taunuuga leaga pe a uma ona pulea le faʻamaʻi. “O le umi o nei vaitau o le 'maualalo viral po o siama', o le tele foi lea le fa'alavelave o fa'ama'i i le lumana'i is tall. “, Warn the authors of the study.

Fa'aitiitia fa'ama'i fa'ama'i pepe, a'afiaga mo tamaiti?

Concretely, some epidemics could be more intense in the years to come. Paediatricians fear this may be the case with fa'ama'i fa'ama'i pipisi o tamaiti, including the number of visits to hospital emergencies and practices decreased significantly during confinement, but also beyond despite the reopening of schools. Among these: gastroenteritis, bronchiolitis (especially due to respiratory syncytial virus), tanesusu, ma'i otitis media, fa'ama'i fa'ama'i pipisi i luga ma lalo ole manava, fa'apea ma fa'ama'i fa'ama'i pipisi. Ua manatua e le 'au e faapea "o latou faʻatupuina o faʻamaʻi pipisi o tamaiti laiti, e masani ona viral, toetoe lava a le mafai ona alofia i totonu. tausaga muamua o le olaga. "

Ae, mo nisi o nei faʻamaʻi, o aʻafiaga leaga e ono iai compensated by vaccinations. O le mea lea e vala'au ai foma'i tamaiti mo le fa'ateleina o le usita'ia o polokalame o tui puipui, ma e o'o lava i le fa'alauteleina o le faitau aofa'i o tagata. Manatua o Iulai talu ai, ua leva ona mataala le Faalapotopotoga o le Soifua Maloloina a le Lalolagi (WHO) ma le Unicef ​​i se pa'ū "mataʻutia" i le numera o tamaiti. mauaina o tui puipui ola i le lalolagi. O se tulaga ona o le faʻalavelaveina o le faʻaogaina o tui puipui ona o le faʻamaʻi COVID-19: 23 miliona tamaiti e leʻi mauaina tui e tolu o le tui faʻasaga i le diphtheria, tetanus ma le pertussis i le 2020, o ai e mafai. mafua ai fa'ama'i fou i tausaga na sosoo ai.

Ae ui i lea, o nisi faʻamaʻi viral e le o le autu o se polokalame tui. Pei o le tanesusu : o tagata uma e fa'akonekarate i le taimi o latou olaga, o le tele o taimi ao laiti, o le tui e fa'atatau mo na'o tagata e lamatia i tulaga ogaoga. I le 2020, 230 mataupu na lipotia, o se faʻaititia o le 000%. E tatau ona totogi le maalofia o le tanesusu, “Young children who should have contracted it in 2020 may contribute to a higher incidence in the years to come,” the researchers say. In addition, these children will have “aged” which could lead to a greater number of serious cases. Faced with this context tulaga lamatia o le toe fa'ama'i, the latter wish to broaden the vaccine recommendations for chickenpox, therefore, but also rotavirus and meningococci B ma le ACYW.

Covid-19 pepe ma le tamaititi: fa'ailoga, su'ega, tui

O a fa'ailoga o le Covid-19 i tupulaga, tamaiti ma pepe? Pe pipisi tele ea tamaiti? Latou te tuʻuina atu le coronavirus i tagata matutua? PCR, faua: o le a le suʻega e faʻamaonia ai le faʻamaʻi pipisi o le Sars-CoV-2 i le uii? Matou te suʻesuʻeina le malamalama e oʻo mai i le taimi nei i le Covid-19 i tupulaga talavou, tamaiti ma pepe.

Covid-19: O tamaiti laiti e sili atu le pipisi nai lo talavou

E mafai e tamaiti ona maua le SARS-CoV-2 coronavirus ma pasi atu i isi tamaiti ma tagata matutua, aemaise lava ile fale e tasi. Ae na fia iloa e le au suʻesuʻe pe sili atu lenei lamatiaga e tusa ai ma le matua, ma e foliga mai o tamaiti i lalo ifo o le 3 tausaga o le a sili atu ona aʻafia i latou o loʻo siomia ai i latou.

E ui o suʻesuʻega na faʻaalia ai e masani lava ona maua e tamaiti fa'aitiitiga ogaoga o le COVID-19 nai lo tagata matutua, e le faʻapea o loʻo faʻaititia e le tagata mulimuli le coronavirus. O le fesili o le iloa pe o ni mea leaga pe itiiti ifo nai lo tagata matutua o loʻo tumau pea, aemaise lava talu ai e faigata mai faʻamatalaga avanoa e iloilo lelei ai a latou matafaioi. i le malosi o le faʻamaʻi. In a new study published in the journal “JAMA Pediatrics”, Canadian researchers wanted to know if there was a clear difference in the probabilities of transmission of SARS-CoV-2 at home. e tamaiti laiti faatusatusa i tamaiti matutua.

E tusa ai ma faʻaiʻuga suʻesuʻega na tuʻuina atu e le New York Times, o pepe pepe ma tamaiti laiti e sili atu ona ono afaina e fa'asalalauina le COVID-19 i isi i o latou aiga nai lo talavou. Ae i le isi itu, o tamaiti laiti e itiiti ifo nai lo talavou e faʻafeiloaʻi le siama. Ina ia oʻo mai i lenei faʻaiuga, na suʻesuʻeina e le au suʻesuʻe faʻamaumauga i luga o suʻega lelei ma o mataupu ole COVID-19 in the province of Ontario between June 1 and December 31, 2020, and have identified more than 6 households in which the first person infected was under the age of 200. They then looked for further cases in those outbreaks within two weeks. le suega lelei o le tamaitiiti muamua.

O tamaiti laiti e sili atu ona pipisi ona e sili atu ona faigata ona vavaeeseina

E aliali mai e 27,3% o tamaiti na maua pisia ia le itiiti ifo ma le tasi le isi tagata from the same household. Adolescents accounted for 38% of all first cases in homes, compared to 12% of children aged 3 and under. But the risk of transmission to other family members was 40% higher when o le tamaititi muamua na aafia e 3 tausaga le matua pe laʻitiiti nai lo le 14 i le 17 tausaga le matua. O nei iʻuga e mafai ona faʻamatalaina e le mea moni e manaʻomia e tamaiti laiti le tele o tausiga faʻapitoa ma e le mafai ona tuʻuesea pe a mamaʻi, o loʻo fautua mai ai le au suʻesuʻe. E le gata i lea, i le matua o tamaiti o le "jack-of-all-trades", e faigata ona faia fa'aaoga taga puipui.

“O tagata ua siitia tamaiti laiti ua masani i le fuga ma fa'afefe i luga o le tau'au. “O Dr. Susan Coffin, o se fomaʻi faʻamaʻi pipisi i le Falemai a Tamaiti i Philadelphia, na taʻu atu i le New York Times. "E leai se mea e faʻafefe ai. Ae fa'aaoga i'a e lafoa'i, fufulu vave ou lima after helping them wipe their noses are things a parent of an infected child can do to limit the spread of the virus in the household. If the study does not answer the questions of whether the infected children are also pipisi nai lo tagata matutua, o lenei mea e faʻaalia ai e oʻo lava i tamaiti laiti e iai se sao faʻapitoa i le faʻasalalauina o faʻamaʻi pipisi.

"O lenei suʻesuʻega e taʻu mai ai o tamaiti laiti atonu e sili atu le faʻalavelave e fa'asalalauina le fa'ama'i nai lo tamaiti matutua, o le maualuga o le lamatiaga o fa'ama'i pipisi na matauina i latou e 0 i le 3 tausaga le matutua. », Faʻaiʻu le au suʻesuʻe. E taua lenei su'esu'ega, talu ai ona sili atu le malamalama i le lamatiaga o le fa'asalalauina o le siama e tusa ai ma vaega o tamaiti matutua e aoga mo le puipuia o fa'ama'i i totonu ole fa'ama'i. Ae faʻapea foʻi i aʻoga ma fale tausi tamaiti, ina ia faʻaitiitia ai le lamatiaga o faʻamaʻi lua i totonu o aiga. E mana'omia e le au fa'asaienisi nisi su'esu'ega i se vaega tele o tamaiti o vaitausaga eseese to establish this risk even more precisely.

Covid-19 and inflammatory syndrome in children: a study explains the phenomenon

I se tulaga e seasea tupu i tamaiti, o le Covid-19 ua mafua ai le telesystem inflammatory syndrome (MIS-C poʻo le PIMS). I se suʻesuʻega fou, o loʻo tuʻuina atu e le au suʻesuʻe se faʻamatalaga mo lenei mea e le o iloa mai le puipuiga.

O le mea e lelei ai, o le toʻatele o tamaiti ua aʻafia i le Sars-CoV-2 coronavirus e atiaʻe ni nai faʻailoga, pe leai foi ni faʻailoga. Saga in very rare cases, Covid-19 in children evolves into multisystemic inflammatory syndrome (MIS-C or PIMS). Afai tatou te talanoa muamua i le faʻamaʻi Kawasaki, o le mea moni o se faʻamaʻi faʻapitoa, lea e faʻasoa faʻapitoa uiga ma faʻamaʻi Kawasaki ae e ese lava.

E fai ma faamanatu, o le multisystem inflammatory syndrome o loʻo faʻaalia e fa'ailoga e pei ole fiva, tiga o le manava, mageso, fatu fatu ma fa'afitauli neura e tupu ile 4 i le 6 vaiaso mulimuli ane. infection with Sars-CoV-2. Diagnosed early, this syndrome is easily treatable with the help of immunosuppressants.

In a new scientific study published on May 11, 2021 in the journal Immunity, researchers at Yale University (Connecticut, USA) attempted to shed light on lenei tulaga o le soona tali atu i le puipuiga.

O le au suʻesuʻe iinei na suʻesuʻeina faʻataʻitaʻiga toto mai tamaiti e maua i le MIS-C, tagata matutua e maua i se tulaga ogaoga o le Covid-19, faʻapea foʻi ma tamaiti soifua maloloina ma tagata matutua. Na maua e le au suʻesuʻe o tamaiti e maua i le MIS-C e iai ni faʻafitauli puipuia e ese mai isi vaega. Sa i ai a latou maualuga maualuga o alarmines, molelaula o le tino puipuia o le tino, lea e faʻagaoioia vave e tali atu i faʻamaʻi uma.

« Innate immunity may be more active in children infected with the virus ”o le tala lea a Carrie Lucas, polofesa o le immunology ma le tusitala o le suʻesuʻega. ” Ae i le isi itu, i se tulaga e seasea tupu, e mafai ona matua fiafia ma saofagā i lenei faʻamaʻi mumu. », She added in a fesoʻotaʻi.

The researchers also found that children with MIS-C exhibited marked elevations in certain adaptive immune responses, defenses to fight specific pathogens – such as coronaviruses – and which generally confer immunological memory. But instead of being protective, the immune responses of some children seem to attack tissues in the body, as in the case of autoimmune diseases.

O lea la, i ni tulaga e seasea ona tupu, o le tali atu a tamaiti e fa'atupuina ai se fa'alavelave fa'alavelave e afaina ai aano o lo'o soifua maloloina. They then become more vulnerable to autoantibody attacks. The researchers hope that this new data will contribute to the early diagnosis and better management of children at high risk of developing this complication of Covid-19.

Covid-19: su'ega su'e isu fa'atagaina mo tamaiti

O le Haute Autorité de Santé ua tuʻuina atu le moli lanumeamata i le faʻapipiʻiina o suʻega antigenic e ala i le nasal swab mo tamaiti i lalo ole 15 tausaga le matutua. O lenei fa'aopoopoga i le la'ititi e tatau ona fa'ateleina su'esu'ega i a'oga, mai le aoga fa'ata'ita'i.

Su'ega antigenic e ala i le nasal swab, fa'atasi ai ma taunuuga vave, are now allowed for children under 15. Ole mea lea ole Haute Autorité de Santé (HAS) faatoa faʻasalalau i se faʻasalalauga faʻasalalau. O nei su'ega o le a fa'aaogaina e su'e ai le Covid-19 i totonu o a'oga, fa'atasi ai ma su'ega faua, lea e fai ma sui o se meafaigaluega fa'aopoopo mo le su'esu'eina o le Covid-19 i le au laiti.

Aisea ua suia ai le fuafuaga?

Selon le HAS, “The lack of studies in children had led the HAS to limit (the use of antigenic tests and self-tests) to those over 15 years old”. Ae ui i lea, a'o fa'aauau su'esu'ega fa'aopoopo, o lo'o fa'asolosolo le ta'iala mo su'esu'ega. “A meta-analysis carried out by the HAS shows encouraging results in children, which now makes it possible to extend the indications and to consider the use of antigenic tests on nasal samples in schools. With a result in 15 to 30 min, they constitute a complementary tool to the salivary RT-PCR tests to break the chains of contamination within the classes ”, lipoti a le HAS.

O le mea lea e tatau ai ona fa'atino su'ega nasal swab i se fua tele i aʻoga “I totonu o vasega pepe ma aoga tulagalua, kolisi, aoga maualuga ma iunivesite, e le gata i tamaiti aoga, faiaoga ma le aufaigaluega e fesootai ma tamaiti aoga”, specifies the HAS.

Le pu o nei su'ega antigenic: e le tu'uina atu i se falesu'esu'e, ma fa'ataga vave su'esu'ega, i luga ole nofoaga, i totonu ole 15 i le 30 minute. E fa'aitiitia fo'i le osofa'i ma itiiti le tiga nai lo le su'ega PCR.

Su'ega antigenic mai le aoga faataitai

Fa'amaoni, fa'apefea ona tupu lenei mea? E tusa ai ma fautuaga a le HAS, “Students, high school and college students can perform the self-test independently (after a first performance under the supervision of a competent adult if necessary). Mo tamaiti aoga tulagalua, e mafai fo'i ona fa'ata'ita'iina muamua le fa'ata'ita'iga a le tagata lava ia, peita'i e sili ona fai le su'ega e matua po'o le aufaigaluega ua a'oa'oina. Mo tamaiti i le aoga faataitai, o le fa'ata'ita'iga ma le su'ega e tatau ona fa'atinoina e ia lava tagata. “ Manatua i le aoga pepe, su'ega faua e fa'atino fo'i.

Po'o le a lava le su'ega su'ega e faia, e tumau i lalo o le faatagaga a matua for minors.

Punavai: Fa'asalalauga fa'asalalau: “Covid-19: the HAS lifts the age limit for the use of antigenic tests on a nasal swab ”

Covid-19 self-test: all about their use, especially in children

E mafai ona tatou faʻaogaina se suʻega a le tagata lava ia e suʻe ai le Covid-19 i la tatou tama? E fa'afefea ona aoga su'ega a le tagata lava ia? O fea e maua ai? Matou te su'eina fa'amaumauga.

O su'ega a le tagata lava ia o lo'o fa'atau atu i fale talavai. I le feagai ai ma le faʻateleina o faʻamaʻi, atonu e faʻaosoosoina le faia o se tasi pe sili atu, aemaise lava le faʻamautinoaina o oe lava.

Covid-19 su'ega a le tagata lava ia: fa'afefea ona aoga?

O suʻega a le tagata lava ia na faʻatau atu i Farani o suʻega antigenic, lea e mafai ai ona faia naʻo le faʻataʻitaʻiga ma le faitauina o le iʻuga, e aunoa ma se fesoasoani faafomaʻi. O nei su'ega e faia e ala i se fa'ata'ita'iga o le isu. The instructions specify that it is a question of introducing the swab vertically into a nostril over 2 to 3 cm without forcing, then gently tilting it horizontally and inserting it a little until meeting a slight resistance. There, it is then necessary feliuliua'i totonu ole puisu. O le faʻataʻitaʻiga e sili atu le papaʻu nai lo le faʻataʻitaʻiga nasopharyngeal faia i taimi masani PCR ma suʻega antigen, lea e faia i totonu o fale suʻesuʻe poʻo se fale talavai.

The result is quick, and appears much like a pregnancy test, after 15 to 20 minutes.

Aisea e fai ai se su'ega a le tagata lava ia Covid?

E fa'aoga le su'ega a le nasal e iloa ai tagata e leai ni fa'ailoga ma e leai ni feso'ota'iga. E mafai ai ona e iloa pe o oe o se ave o le Sars-CoV-2 pe leai, ae e naʻo le fiafia pe a fai masani, taʻi lua i le tolu aso, faʻamaonia faatonuga.

Afai e iai ni au fa'ailoga po'o ua e fa'afeso'ota'i ma se tagata na fa'amaonia lelei, e fautuaina e te faia se su'ega PCR masani, sili atu ona fa'atuatuaina. Aemaise lava talu ai o le mauaina o se taunuuga lelei i se suʻega a le tagata lava ia e manaʻomia le faʻamaoniga o le suʻesuʻega e PCR.

E mafai ona fa'aoga su'ega a le tagata lava ia i tamaiti?

I se manatu na tuʻuina atu ia Aperila 26, ua fautuaina nei e le Haute Autorité de Santé (HAS) le faʻaaogaina o suʻega a le tagata lava ia mo i latou i lalo ifo o le 15 tausaga.

I le tulaga o faʻailoga e faʻaalia ai le Covid-19 ma faʻaauau pea i se tamaititi, aemaise lava i le fiva, e fautuaina le faʻaesea o le tamaititi ma faʻafesoʻotaʻi se fomaʻi poʻo se fomaʻi, o le a faʻamasinoina le manaʻoga e fai se suʻega. su'esu'e mo le Covid-19 (PCR po'o le antigen, po'o le faua fo'i pe afai e le'i atoa le 6 tausaga le matua). E taua tele le su'esu'ega o le tino ina ia aua ne'i misia se fa'ama'i e sili atu ona ogaoga i le tamaititi, e pei o le ma'i fiva fai'ai.

O lea e sili ai le aloese mai le faia o suʻega a le tagata lava ia i tau uma, a itiiti ifo i tamaiti. A uma mea uma, o le gaioiga o faʻataʻitaʻiga o loʻo tumau pea le osofaʻi ma atonu e faigata ona faʻatino saʻo i tamaiti laiti.

[I le aotelega]

• I le aotelega, o tamaiti ma pepe e foliga mai e itiiti le afaina i le Sars-CoV-2 coronavirus, ma a oʻo i latou, latou te atiaʻe. fa'ailoga fa'aletonu nai lo tagata matutua. Lipoti tusi faasaienisi asymptomatic or not very symptomatic i tamaiti, e masani lava, ma fa'ailoga vaivai (malili, fiva, fa'aletonu o mea'ai tele). I pepe, aemaise lava le fivalea e pule, pe a latou atiina ae se fa'ailoga fa'ailoga.
• I tulaga e seasea tupu, Covid-19 i tamaiti e mafai ona mafua ai multisistem pupuga faʻapitoa, MIS-C, affection close to Kawasaki disease, which can affect the coronary arteries. Serious, this syndrome can nevertheless be managed in intensive care and lead to a complete cure.
• O le mataupu o le Sars-CoV-2 coronavirus felauaiga i tamaiti ua avea ma autu o felafolafoaiga ma le tele o suʻesuʻega e feteenai iʻuga. E foliga mai, e ui i lea, o loʻo tulaʻi mai se maliega faʻasaienisi, ma o lenamuamua fa'aitiitia e tamaiti le fa'ama'i nai lo tagata matutua. O le a sili atu foi ona afaina i latou i nofoaga tumaoti nai lo le aʻoga, aemaise lava talu ai o matapulepule ma pa puipui e faʻatagaina i totonu o aʻoga.
• E pei tofotofoga e iloa ai le iai o le coronavirus, le antigen suʻega ua fa'atagaina nei i tamaiti i lalo ifo o le 15 tausaga le matutua, ia i latou fa'apea fo'i ma su'ega faua,  
• O le n'existe a priori leai se fa'alavelave i le tuiina o tamaiti. O suʻega na faia e le Pfizer ma le BioNTech e maua ai le puipuiga lelei mai le coronavirus i tamaiti. A'o le'i faia tui puipui o tamaiti, e tatau ona maua e fale su'esu'e le maliega a pulega fa'atonutonu eseese i le lalolagi.

AstraZeneca Fa'agata Su'ega Tu'i Covid i Tamaiti

If Pfizer & BioNTech announces a 100% effectiveness of its vaccine in young people from 12 to 15 years old, for the moment AstraZeneca stops its trials in the youngest. We take stock.

Fa'ata'ita'iga fa'afoma'i, fa'atino i luga o le sili atu 2 200 talavou in the United States, show a 100% efficacy of the Pzifer-BioNTech vaccine in 12-15 year olds. They could therefore be vaccinated before the start of the school year in September 2021.

O se amataga ia Fepuari

Mo lana vaega, AstraZeneca fale suesue na amata foi su'ega falema'i Fepuari talu ai, i Peretania, i luga o le 240 tamaiti mai le 6 i le 17 tausaga, ina ia mafai ona amata se tui puipuia o le Covid of the youngest before the end of 2021.

Suspended trials

E oʻo mai ia Mati 24, i Peretania, 30 mataupu o le thrombosis na tupu i tagata matutua ina ua maeʻa le tui ile AstraZeneca. Faatasi ai ma nei mataupu, 7 tagata na maliliu.

Since then, some countries have completely suspended vaccination with this product (Norway, Denmark). Others like France, Germany, Canada, only offer it from the age of 55 or 60, depending on the country.

This is why clinical trials in British children are on hold. The University of Oxford, where these tests were taking place, is awaiting the authorities’ decision to know whether or not it is possible to resume them.

I le taimi nei, o tamaiti na auai i le suʻega a le AstraZeneca e tatau ona faʻaauau pea ona auai i asiasiga faʻatulagaina.

Covid-19: Pfizer and BioNTech announce that their vaccine is 100% effective in 12-15 year olds

Fai mai Pfizer ma BioNTech laboratories o latou tui e maua ai le malosi o le antibody e faasaga ia Covid-19 i tupulaga talavou 12 i le 15 tausaga. 

Le Pfizer & BioNTech tui o le tui muamua lea e faasaga i le Covid-19 na faʻamaonia i le faaiuga o le 2020. E oʻo mai i le taimi nei, o loʻo faʻatagaina lona faʻaogaina mo tagata e 16 tausaga ma luga atu. E mafai ona suia lenei mea pe a maeʻa le vaega 3 faʻataʻitaʻiga faʻataʻitaʻi lea faatoa faia.

100% lelei

faamanuiaga su'ega falema'i o le mea moni sa faataunuuina i luga 2 260 talavou i Amerika. Semanu latou te faaalia a 100% lelei vaccine against Covid-19, including the British variant of the virus.

Fai tui ae lei oo ia Setema?

Ina ua maeʻa le 12-15 tausaga, na faʻalauiloa le fale suʻesuʻe tofotofoga i tamaiti laiti: 5 i le 11 tausaga le matutua. Ma mai le vaiaso a sau, o le a oʻo i le taimi o tamaiti laiti: mai le 2 i le 5 tausaga le matua.

O lea la, Pfizer-BioNTech faʻamoemoe e mafai ona amata vaccination of children and adolescents before the next school year in September 2021. Ina ia faia lenei mea, e tatau ona latou mauaina muamua le maliega a pulega faʻatonutonu eseese i le lalolagi atoa.

E fia tui puipui?

E oʻo mai i le taimi nei, ua tufatufaina atu e le Pfizer-BioNTech le 67,2 miliona tui o lana tui i Europa. Ona, i le kuata lona lua, o le a 200 miliona tui.

Covid-19: o afea e tatau ai ona fai se su'ega o la'u tama?

E ui e le o faʻavaivaia le faʻamaʻi Covid-19, o loʻo mafaufau matua. E tatau ona e su'e lau tama mo sina malulu? O a faʻailoga e tatau ona mafaufau ai se tasi ile Covid-19? O le a le taimi e fa'atalanoa ai ile fiva po'o le tale? Faʻamatalaga faʻatasi ma Polofesa Delacourt, ieditor at the Necker Sick Children Hospital and President of the French Pediatric Society (SFP).

E le faigofie i taimi uma ona iloa faʻailoga o le malulu, o le bronchitis, mai le Covid-19. O le mea lea e mafua ai le popolega o matua, faapea foi ma le tele o le tuliesea o aoga mo fanau.

Manatua o faʻamaoniga o faʻamaʻi pipisi i le coronavirus fou (Sars-CoV-2) e masani lava ona tauagafau i tamaiti, lea tatou te matauina. fa'aitiitia fo'i tuga ma le tele o fa'ama'i, Na faailoa mai e Polofesa Delacourt e faapea fiva, fa'afitauli o le manava ma o nisi taimi fa'aletonu manava were the main signs of infection in the child. “Pe a iai ni fa'ailoga (fiva, fa'alavelave manava, tale, fa'afitauli o le manava, fa'amatalaga a le fa'atonu) ma fa'afeso'ota'i ma se fa'ama'i fa'amaonia, e tatau ona fa'afeso'ota'i le tamaititi ma faia se su'ega.”, Faailoa mai e Polofesa Delacourt.

I le tulaga o faʻamaoniga, "lelei aveese le tamaitiiti mai le nuu (aoga, vasega pepe, fesoasoani i le vasega pepe) i le taimi lava e i ai se masalosalo, ma saili fautuaga faafomai. “

COVID-19: o le puipuiga a tamaiti o le a puipuia i latou mai se faʻamaʻi ogaoga

O se suʻesuʻega na lomia ia Fepuari 17, 2021 na faʻaalia ai e sili atu le puipuia o tamaiti mai le ogaoga o le COVID-19 nai lo tagata matutua ona e vave osofa'i atu o latou tino mai le puipuiga le coronavirus a o leʻi toe faia i le tino.

Talu ai ona e tau le masani ma itiiti le aʻafia i le SARS-CoV-2 nai lo tagata matutua, o le mauaina o le malamalama e uiga i le Covid-19 i tamaiti e tumau pea le faigata. E lua fesili e aliaʻe mai nei faʻamaʻi faʻamaʻi: why are children less affected et o fea e sau ai nei mea fa'apitoa? These are important since research in children will allow advances in adults: it is by understanding what differentiates the behavior of the virus or the body’s response according to age that it will be possible to ” identify mechanisms to target. Researchers at the Murdoch Institute for Research on Children (Australia) put forward a hypothesis.

O la latou suʻesuʻega, lea e aofia ai suʻesuʻega o suʻesuʻega toto mai le 48 tamaiti ma le 70 tagata matutua, ma lomia i le tusitala faasaienisi Nature Communications, fai mai o tamaiti o le a sili atu ona puipuia mai ituaiga ogaoga ole COVID-19 ona o lo latou fa'aletino fa'aletino osofa'i vave le siama. I ni faaupuga faʻamaonia, o sela faʻapitoa o le puipuiga a le tamaititi e sili atu le vave o le SARS-CoV-2 coronavirus. E talitonu tagata suʻesuʻe o mafuaʻaga e maua ai e tamaiti le faʻamaʻi COVID-19 faʻatusatusa i tagata matutua ma o le puipuiga o loʻo i lalo o lenei puipuiga e leʻi iloa seʻia oʻo i lenei suʻesuʻega.

O auga e masani ona vaivai i tamaiti

« E itiiti lava le ono a'afia o tamaiti i le siama ma e o'o atu i le tasi vaetolu o i latou e leai ni fa'aaliga, lea e matua'i ese lava mai le maualuga maualuga ma le ogaoga o lo'o va'aia mo le tele o isi fa'ama'i manava.fai mai Dr Melanie Neeland, o le na faia le suʻesuʻega. O le malamalama i le faʻavaeina o le eseesega o tausaga i le ogaoga o le Covid-19 o le a maua ai faʻamatalaga taua ma avanoa mo le puipuia ma togafitiga, mo le Covid-19 ma mo faʻamaʻi i le lumanaʻi. O tagata uma na auai na aʻafia pe faʻaalia i le SARS-CoV-2, ma na mataʻituina a latou tali i le taimi o faʻamaʻi pipisi ma e oʻo atu i le lua masina mulimuli ane.

O le avea ma faʻataʻitaʻiga o se aiga e toʻalua tamaiti, e lelei mo le coronavirus, na maua ai e le au suʻesuʻe o teineiti e to'alua, e 6 ma le 2 tausaga, na'o sina susu la'ititi, while the parents experienced extreme fatigue, headaches, muscle pain, and suffered loss of appetite and taste. It took them two weeks to fully recover. To explain this difference, the researchers found that infection in children was characterized by faʻagaoioia o neutrophils (selau pa'epa'e o lo'o fesoasoani e fa'amālōlōina aano ua fa'aleagaina ma fo'ia fa'ama'i pipisi), ma e ala i le fa'aitiitia o le vave tali atu o sela puipuia, e pei o sela fa'alenatura i le toto.

O se tali puipuia e sili atu ona aoga

« O lo'o fa'ailoa mai ai o nei sela fa'ama'i fa'ama'i fa'ama'i e alu atu i nofoaga o fa'ama'i, vave fa'ate'aina le siama a'o le'i maua le avanoa e pu'e moni ai. Adds Dr Melanie Neeland. O loʻo faʻaalia ai o le faʻaogaina o le tino puipuia, o la tatou laina muamua o le puipuiga mai siama, e taua tele i le puipuia o le COVID-19 ogaoga i tamaiti. O le mea taua, e le'i toe fa'atusaina lenei tali fa'aletonu i tagata matutua i le su'esu'ega. Na fa'afiafiaina fo'i le 'au fa'asaienitisi i le mauaina e o'o lava i tamaiti ma tagata matutua na a'afia i le coronavirus, ae o ana su'esu'ega na foliga mai e le lelei, na toe suia fo'i tali puipuia.

According to the researchers, “ children and adults had an increased neutrophil count for up to seven weeks after exposure to the virus, which could have provided a level of protection against the disease “. O nei suʻesuʻega e faʻamaonia ai le iʻuga o se suʻesuʻega talu ai na faia e le au lava e tasi lea na faʻaalia ai e toʻatolu tamaiti mai le aiga Melepone na atiaʻe se tali faʻatumauina tutusa ina ua umi ona aafia i le coronavirus mai o latou matua. E ui o nei tamaiti na aʻafia i le SARS-CoV-2, ae na latou atiina ae se tali puipuia lelei e puipuia ai le siama mai le toe faia, o lona uiga latou te e le'i maua lava se su'ega lelei.

Fa'ailoga o le pa'u na lipotia i tamaiti

The National Union of Dermatologists-Venereologists mentions possible manifestations on the skin.

« For now, we see in children and adults redness of the extremities and sometimes papa'u laiti i lima ma vae, ile taimi ole fa'ama'i ole COVID. O lenei faʻamaʻi o le mea e foliga mai o le malulu e le masani ai ma o loʻo o gatasi ma faʻafitauli faʻamaʻi COVID. Atonu o se ituaiga la'ititi o le fa'ama'i COVID, pe o se faʻaaliga tuai pe a maeʻa le faʻamaʻi na semanu e le iloa, poʻo se siama e ese mai i le COVID lea e oʻo mai i le taimi e tasi ma le faʻamaʻi o loʻo iai nei. O loʻo matou taumafai e malamalama i lenei faʻalavelave », Explains Professor Jean-David Bouaziz, dermatologist at Saint-Louis Hospital.

Coronavirus: o a aʻafiaga ma faʻalavelave mo tamaiti?

E ese mai i tagata mamaʻi na aʻafia ma toe malosi, e leai se tasi e puipuia moni mai faʻamaʻi i le coronavirus fou. I se isi faaupuga, o tagata uma, e aofia ai pepe, tamaiti ma fafine maʻitaga, e faigofie ona maua i le siama.

However, according to existing data, children seem rather spared. They are relatively unaffected, and when infected with Covid-19, they tend to have foliga mama. A tupu faʻalavelave i tupulaga talavou, e masani ona fesoʻotaʻi ma isi mafuaʻaga. O le mea lea e taʻua e fomaʻi o le "comorbidity", o lona uiga, o le i ai o aʻafiaga lamatia e fesoʻotaʻi ma se isi faʻamaʻi.

O faʻafitauli matuia e fesoʻotaʻi ma Covid-19 o e matua seasea lava i tamaiti ma talavou. But they are not totally excluded, as the deaths that have occurred in several of them since the start of the epidemic are painful reminders.

I se mataupu i Le Parisien, na taʻua ai e Dr. Robert Cohen, fomaʻi o tamaiti, o tausaga taʻitasi, “oE le o iloa pe aisea i nisi o nei faʻamaʻi pipisi e le lelei. O fa'ama'i fa'ama'i o nisi taimi e le taumateina ae e seasea. E te silafia i tausaga uma e feoti ai foi tamaiti i le fulū, misela ma le tanesusu ".

O le a le MIS-C, le faʻamaʻi fou e fesoʻotaʻi ma le Covid-19 e aʻafia ai tamaiti?

Faatasi ai ma le amataga o le Covid-19, o se isi faʻamaʻi, na aʻafia ai tamaiti, na aliaʻe. E latalata ile Kawasaki syndrome, ae e ese lava.

It is sometimes called PIMS, sometimes MISC… Recalling Kawasaki disease, this syndrome which has affected at least a thousand children around the world since the Covid epidemic is intriguing researchers. He is now named multisystem inflammatory syndrome in children, or MIS-C.

MIS-C o le a aliali mai pe a ma le 1 masina talu ona fa'ama'i ile Covid-19

E tusa ai ma suʻesuʻega e lua, lomia Aso Gafua, Iuni 29, 2020 i le " New England Journal of Medicine », O faʻamaoniga o lenei faʻamaʻi e aliali mai i ni nai vaiaso talu ona faʻamaʻi pipisi i le SARS-CoV-2 virus, o se vaeluaga o le 25 aso e tusa ai ma se suʻesuʻega muamua a Amerika. O le isi suʻesuʻega na faia i Niu Ioka e taofi mo se vaitaimi e tasi le masina talu ona maeʻa le faʻaleagaina muamua.

MIS-C ona o le Covid-19: o se lamatiaga sili atu e tusa ai ma ituaiga?

The disease is still confirmed as very rare: 2 cases per 100 people under the age of 000. Researchers in both studies found that the affected children were more black, Hispanic, or Indian-born children, compared to white children.

O a fa'ailoga ole MIS-C?

O le fa'ailoga sili ona taatele i lenei su'esu'ega i tamaiti ua a'afia e le o le manava. E silia ma le 80% o tamaiti na mafatia i faaletonu o le manava (tiga o le manava, faufau po'o pua'i, manava manava), ma e to'atele ua o'o iai paʻu o le paʻu, aemaise i latou e i lalo ifo o le lima lima. Sa maua uma i le fiva, e masani lava mo le sili atu i le fa pe lima aso. And in 80% of them, the cardiovascular system was affected. 8-9% of children have developed a coronary artery aneurysm.

I le taimi muamua, o le tele o tamaiti sa soifua maloloina lelei. Latou te leʻi faʻaalia se tulaga lamatia, poʻo se faʻamaʻi muamua. 80% na fa'atagaina i le tausiga tigaina, 20% na maua le manava manava, ma 2% na maliliu.

MIS-C: different from Kawasaki syndrome

I le taimi muamua na aliali mai ai le faʻamaʻi, na matauina e fomaʻi le tele o mea e tutusa ai ma le kawasaki maladie, o se fa'ama'i e masani ona afaina ai pepe ma tamaiti laiti tele. O le tulaga mulimuli e tupu ai le mumu o alatoto e mafai ona mafua ai faafitauli i le fatu. O fa'amaumauga fou e fa'amaonia ai e iai mea e tutusa ai le MIS-C ma le Kawasaki, ae o le fa'ama'i fou e masani ona a'afia ai tamaiti matutua, ma fa'atupu ai le fula tele.

O le mea lilo o loʻo tumau pea ona faʻamalamalamaina i mafuaʻaga o lenei alofa fou. O le a feso'ota'i atu i le le lava o le tali atu a le puipuiga.

Tamaiti, "aveina maloloina", pe faʻasaoina mai le coronavirus?

I le amataga o le faʻamaʻi o le coronavirus, na toetoe lava a le amanaiaina o tamaiti o le tele o tagata soifua maloloina: o lona uiga, latou te mafaia. ave le siama e aunoa ma ni fa'ailoga o le ma'i, e sili atu ona faigofie i le taimi o a latou taaloga i lo latou va, ma o latou aiga. O le mea lea na faʻamatalaina ai le faʻaiuga e tapunia aʻoga ma fale tausimai, e puipuia ai le sosolo o le faʻamaʻi o le coronavirus. 

But what we took for a certainty is today called into question. A recent study tends to prove that, ultimately, children transmit the coronavirus little. “E mafai o tamaiti, ona e le tele ni a latou faailoga ma maua ose viral load maualalo itiiti le fa'asalalauina o lenei coronavirus fou ", Kostas Danis, epidemiologist i le Public Health Farani ma taʻitaʻia tusitala o lenei suʻesuʻega, taʻu atu ia AFP.

Covid-19, colds, bronchitis: how do you sort things out?

As winter approaches and while the Covid-19 epidemic does not abate, parents are wondering. Should you have your child tested for the slightest cold? What are the symptoms that should make one think of Covid-19? O afea e fa'atalanoa ai mo le fiva po'o le tale? Faʻamatalaga faʻatasi ma Prof. Delacourt, fomaʻi i le Necker Children Sick Hospital ma le Peresetene o le French Pediatric Society (SFP).

E le faigofie i taimi uma ona iloa faʻailoga o le malulu, o le bronchitis, mai le Covid-19. O le mea lea e mafua ai le popolega o matua, faapea foi ma le tele o le tuliesea o aoga mo fanau.

Covid-19: what to do in case of symptoms in children?

I le manatuaina o faʻamaoniga o faʻamaʻi pipisi i le coronavirus fou (Sars-CoV-2) e masani lava ona tauagafau i tamaiti, lea e itiiti ni faʻamaʻi ogaoga ma le tele o faʻamaʻi asymptomatic, na faʻaalia e Polofesa Delacourt e faapea. fiva, fa'alavelave fa'ananānā ma o nisi taimi fa'alavelave manava o fa'ailoga autu ia o le fa'ama'i i le tamaititi. "A iai ni fa'ailoga (fiva, fa'alavelave manava, tale, fa'afitauli o le manava, fa'amatalaga a le fa'atonu) ma ua fa'afeso'ota'i ma se fa'ama'i fa'amaonia, e tatau ona fa'atalanoa le tamaititi ma fa'ata'ita'i., indique le Pr Delacourt.

I le tulaga o fa'ailoga, " e sili atu le aveese o le tamaitiiti mai le nuu (aoga, vasega pepe, fesoasoani i le vasega pepe) i le taimi lava e i ai se masalosalo, ma saili fautuaga faafomai. »

Coronavirus: few symptoms in babies except fever

Fai mai tagata suʻesuʻe Amerika i se suʻesuʻega na lomia ia Setema 2020, o pepe e maua i le COVID-19 e masani ona pagatia i se maʻi vaivai, e masani ona o mai ma le fiva. Ma o lenei mea e ui lava i le mea moni o suʻega suʻega e faʻamaonia ai le i ai o se viral load.

Mai le amataga ole fa'ama'i ole COVID-19, o le faʻamaʻi e foliga mai e le afaina tele tamaiti laiti, o lea e itiiti ni faʻamatalaga a saienitisi e suʻesuʻe ai le aafiaga o le SARS CoV-2 i lenei faitau aofaʻi. Ae o se suʻesuʻega laʻititi o le 18 pepe e leai se tala faʻasolopito taua ma lomia i totonu ” Le Journal of Pediatrics Tuuina atu faʻamatalaga faʻamautinoa. Fai mai fomai i le Ann & Robert H. Lurie Pediatric Hospital i Chicago infants under 90 days tested positive O le COVID-19 e masani ona lelei, e itiiti pe leai foi se manava, ma o le fiva sa masani ona manatu o le autu pe naʻo le faʻailoga.

« E ui lava e itiiti lava a matou faʻamatalaga i lugapepe ma Covid-19i le Iunaite Setete, o a matou faʻaiʻuga o loʻo faʻaalia ai le tele o nei pepe fa'ailoga vaivai ma atonu e le sili atu le lamatia o le atiaʻe o se tulaga ogaoga o le faʻamaʻi e pei ona talanoaina muamua i Saina Fai mai Dr. Leena B. Mithal, taʻitaʻi tusitala o le suʻesuʻega. “ O le tele o pepe i la matou suʻesuʻega na maua i le fiva, e faʻapea i pepe laitio ē taupulepule ona o le fiva, Covid-19 e mafai ona avea ma mafuaʻaga taua, aemaise lava i itulagi o loʻo atiaʻe ai faʻalapotopotoga. Ae ui i lea, e taua foi le mafaufau i siama siama i pepe laiti e maua i le fiva. »

Fiva, tale ma fa'ailoga o le manava, fa'ailoga fa'ailoga

O le suʻesuʻega o loʻo faʻamaonia ai le 9 o nei meana fa'ataga tamaiti i le falema'i ae e le'i mana'omia se fesoasoani manava po'o se tausiga tigaina. O le vaega mulimuli na fa'atagaina mo le mata'ituina o le falema'i, mata'ituina o le fa'apalepale o mea'ai, fa'ama'i fa'ama'i fa'ama'i fa'ama'i fa'ama'i toto i pepe i lalo ole 60 aso le matutua. Faatasi ai ma nei pepe e 9, e 6 i latou na tuuina atu fa'ailoga gastrointestinal (leai se fia'ai, pua'i, manava tatā) e muamua ile tale ma le pipii o le manava pito i luga. E toavalu foi i latou na auai na'o le fiva, ma le toafa e tale po o le malosi o le manava.

After carrying out tests for the direct detection of the infection using the PCR technique (from a biological sample, most often nasopharyngeal), the doctors observed thattamaiti laiti had particularly high viral loads in their samples, despite mild clinical illness. ” It is not clear whether young infants with fever andtested positive for SARS-CoV-2must be hospitalized Adds Dr Leena B. Mithal. ” O le fa'ai'uga e fa'ataga se tagata ma'i i le falema'i e fa'avae i luga o le matua, mana'oga mo togafitiga puipuia mo fa'ama'i siama, su'esu'ega a le falema'i, ma le fa'apalepale o mea'ai. »

E tasi le mea e mautinoa, peitaʻi: e fautuaina e le vaega faasaienisi le faʻaaogaina rapid screening for SARS-CoV-2i tulaga ia o lo'o lelei le soifua maloloina o pepe ae maua i le fiva. E tatau ona maitauina o le tele o suʻesuʻega o loʻo faia ina ia mafai ai ona iloa pe o iai se sootaga i le va o le fa'ama'i Kawasaki ma le Covid-19 talu ai o se faʻaputuga le masani o mataupu na matauina i Farani ma fafo. E tusa ai ma le Academy of Medicine, o se faʻamaʻi ese lea, e pei ona matauina o faʻamaoniga (tiga ogaoga o le manava, faʻailoga o le paʻu) o loʻo tuʻufaʻatasia i lalo o le igoa o le "pediatric multisystem inflammatory syndrome" ma le matua o tamaiti na aʻafia (9 i le 17 tausaga). e maualuga atu nai lo le fa'ama'i masani o le Kawasaki.

Covid-19: pepe laiti e a'afia ile fa'ama'i

A Canadian study published in December 2020 examining the clinical characteristics and severity of Covid-19 shows that o pepe e maua i le fa'ama'i o lo'o lelei tele. O le mea moni, o le tele o pepe na su'esu'eina e masani lava ona maua i le fiva, o se ma'i vaivai ma e le mana'omia se fa'avevela fa'ainisinia po'o se togafitiga tigaina.

Covid-19 is a disease that affects very differentlytagata matutua, tamaiti… ma pepe. O se suʻesuʻega na faia e tagata suʻesuʻe i le Iunivesite o Montreal ma lomia i le JAMA Network tatala faʻaalia o le mea mulimuli, faʻatusatusa i tagata matutua, e lelei tele pe a aʻafia i le SARS-CoV-2. E ui o pepe e maualuga atu le lamatiaga o le atiaʻe o maʻi tuga ma faʻalavelave mai isi faʻamaʻi masani (flu, respiratory syncytial virus), ae faʻafefea le faʻamaʻi o loʻo i ai nei?

O le suʻesuʻega, na faia i le CHU Sainte-Justine i pepe (i lalo ifo o le 1 tausaga le matua) na maua i le Covid-19 i le taimi o le galu muamua o le faʻamaʻi i le va o le ogatotonu o Fepuari ma le faaiuga o Me 2020, o loʻo faʻaalia ai e toʻatele na vave ona toe malosi ma na'o ni fa'ailoga mama tele.O le suʻesuʻega o loʻo faʻamaoti mai ai i Quebec ma Kanata atoa, o pepe e sili atu le maualuga o le falemaʻi ona o Covid-19 nai lo isi tamaiti matutua vaega. Ua faailoa mai e le au suʻesuʻe mai le 1 pepe na tofotofoina, 165 oi latou (25%) fa'ailoa lelei mo Covid-19 ma o i latou nei e itiiti ifo i le tasi vaetolu (8 pepe) sa tatau ona taofia i le falemai, o nei nofo e lua aso i le averesi.

Ole maualuga ole falema'i ae...

E tusa ai ma le vaega faasaienisi, "these short hospitalizationse masani ona atagia ai le masani a le falema'i e faapea o pepe fou uma e maua i le fiva e talia mo le mata'ituina, faia se siaki fa'ama'i ma maua vaila'au fa'atalitali i'uga. In 19% of cases, other infections, such as urinary tract infections, were responsible for the fever in the infant. More importantly, in 89% of cases, coronavirus e mama ma e leai se pepe e mana'omia le okesene po'o le fa'a'avevela masini. O fa'ailoga sili ona taatele o fa'ailoga i le gastrointestinal tract, sosoo ai ma le fiva ma fa'aaliga pito i luga o le manava.

E le gata i lea, e leai se eseesega tele i le falemaʻi i le va o pepe matutua (3 i le 12 masina) ma laiti (itiiti ifo i le 3 masina) na matauina. “ Fa'ailoga falema'i male ogaoga o le ma'iin infants in our series differ from those reported in children and older adults. Our patients presented with a predominance of gastrointestinal symptoms, even in the absence of fever, and generally mild illness. », latou te faaopoopo mai. E ui lava o le suʻesuʻega e faʻatapulaʻaina i lona laʻititi laʻititi laʻititi, e talitonu le au suʻesuʻe o latou sailiga e tatau ona faʻamautinoa ai matua e uiga i taunuuga. of coronavirus infection i pepe.

O se suʻesuʻega fou o le a faia i le CHU Sainte-Justine e malamalama ai i le eseesega o le tali atu o le immunological i le SARS-CoV-2.in infants and their parents.E manaʻomia foʻi nisi galuega e malamalama atili ai i faiga faʻapitoa o le pathophysiological o loʻo faʻavaeina le tali atu i faʻamaʻi pipisi i pepe. Talu ai o loʻo tumau pea se fesili taua: aisea e ese ai faʻailoga falemaʻi ma le ogaoga o le faʻamaʻi i pepe mai mea na lipotia i tamaiti ma tagata matutua? ” E mafai ona avea lea ma elemene autu i le foia o le ma'i o lo'o a'afia aii fa'ama'i pipisi i le SARS-CoV-2i tagata matutua », Faʻaiʻu le au suʻesuʻe.